China's Hepalink to acquire US API business
This article was originally published in Scrip
Executive Summary
Shenzhen Hepalink Pharmaceutical will acquire Waunakee, Wisconsin-based Scientific Protein Laboratories (SPL) for $337.5m in cash plus certain contingent payments.